Biotech ETF Overview

With 16 ETFs traded in the U.S. markets, Biotech ETFs gather total assets under management of $14.00B. The average expense ratio is 0.76%. Biotech ETFs can be found in the following asset classes:

  • Equity

The largest Biotech ETF is the iShares NASDAQ Biotechnology ETF IBB with $6.99B in assets. In the last trailing year, the best performing Biotech ETF was the BBH at 13.37%. The most-recent ETF launched in the Biotech space was the Global X Genomics & Biotechnology ETF GNOM in 04/05/19.

Top ETF Performers

UBIO ProShares UltraPro Nasdaq Biotechnology 27.58%
LABU Direxion Daily S&P Biotech Bull 3X Shares 24.81%
BIB ProShares Ultra NASDAQ Biotechnology 18.06%
CNCR Loncar Cancer Immunotherapy ETF 15.00%
BBC Virtus LifeSci Biotech Clinical Trials ETF 10.97%

Bottom ETF Performers

ZBIO ProShares UltraPro Short Nasdaq Biotechnology -22.33%
LABD Direxion Daily S&P Biotech Bear 3X Shares -21.89%
BIS ProShares UltraShort Nasdaq Biotechnology -15.91%
CHNA Loncar China BioPharma ETF 5.58%
PBE Invesco Dynamic Biotechnology & Genome ETF 7.38%

Top Creations

BIS ProShares UltraShort Nasdaq Biotechnology 0.83
BBC Virtus LifeSci Biotech Clinical Trials ETF 0
CHNA Loncar China BioPharma ETF 0
ZBIO ProShares UltraPro Short Nasdaq Biotechnology 0
BBP Virtus LifeSci Biotech Products ETF 0

Top Redemptions

IBB iShares NASDAQ Biotechnology ETF -232.75
XBI SPDR S&P Biotech ETF -176.50
LABU Direxion Daily S&P Biotech Bull 3X Shares -81.46
FBT First Trust NYSE Arca Biotechnology Index Fund -74.79
BBH VanEck Vectors Biotech ETF -6.21

AUM Winners

LABD Direxion Daily S&P Biotech Bear 3X Shares 41.54%
CHNA Loncar China BioPharma ETF 15.44%
GNOM Global X Genomics & Biotechnology ETF 14.61%
CNCR Loncar Cancer Immunotherapy ETF 12.33%
XBI SPDR S&P Biotech ETF 10.94%

AUM Losers

ZBIO ProShares UltraPro Short Nasdaq Biotechnology -23.62%
LABU Direxion Daily S&P Biotech Bull 3X Shares -4.92%
BIS ProShares UltraShort Nasdaq Biotechnology -2.02%
UBIO ProShares UltraPro Nasdaq Biotechnology 0.36%
BBP Virtus LifeSci Biotech Products ETF 2.32%

ETF Report

 Sectors In Review: November 2019

Sector ETFs did fairly well during the month, with a few exceptions

ETF Report

Sectors In Review: September 2019

Sector ETFs recorded largely positive performance during July.

ETF Report

Sectors In Review: June 2019

Health care and real estate struggled during the month.

Features and News

How To Know What’s In Your ETF

Our free tools and resources can help with your due diligence efforts.

ETF Report

Smart Beta: Beyond The Hype

Despite all the buzz, advisors have reasons to be wary of such strategies.

Features and News

Politics Weigh On Health Care ETFs

Fears of Medicare-for-all are weighing on health care ETFs. Is this an opportunity?

Daily ETF Watch

ETF Week: Zero-Fee Funds Debut

Plus, the first space ETF rolls out.

Features and News

Worst Performing ETFs Of Q1 2019

These ETFs stand out for their poor performance in a strong year for financial markets.

ETF Report

Sectors In Review: April 2019

Sector ETFs had a mostly positive February.